Pruritus is a frequent symptom in chronic cholestatic liver disease. To date, no single causative mechanism has been identified. We examined venous plasma concentrations of the known pruritogen, histamine, using a highly sensitive radioenzymatic assay in 42 patients with chronic cholestatic liver disease, and in normal controls. The mean plasma histamine level was significantly greater in chronic cholestatic liver disease patients (275 (117) pg/ml; x (SD) than in controls (140 (72) pg/ml, n=20) (p<00001). No significant differences were found between histamine concentrations in the two chronic cholestatic liver disease subgroups: primary biliary cirrhosis and sclerosing cholangitis. Histamine concentrations were significantly greater (p<001) in the pruritic (319 (132) pg/ml) as compared with the non-pruritic (227 (75) pg/ml) chronic cholestatic liver disease patients. The histaminase activity was equivalent in patients and controls. The finding of raised histamine concentrations in chronic cholestatic liver disease suggests in vivo mast cell activation and a potential role for its mediators in the pruritus characteristic of these disorders.
Pruritus is a common symptom in chronic cholestatic liver disease. In a recently published study of over 300 patients with two major cholestatic disorders, primary biliary cirrhosis and primary sclerosing cholangitis, 70% suffered with pruritus.' Despite numerous investigations, the aetiology of the pruritus remains unclear, and multiple factors may be involved.2 Theories implicating a role for bile acids in pruritus have been rejected in recent years, and the mechanism for the relief obtained by some patients from use of the exchange resin cholestyramine is yet to be adequately explained. 23 We postulated that histamine, a well described pruritogen in mast cell mediated allergic disorders, may also play a role in the pruritus of chronic cholestasis.5 To test this hypothesis, we determined plasma histamine concentrations in both pruritic and non-pruritic patients with either primary biliary cirrhosis or primary sclerosing cholangitis as well as a control group without liver disease or pruritus. We found that plasma histamine concentrations are raised in patients with chronic cholestatic liver disease. These findings implicate mast cell activation as an aetiologic factor in the cause of the pruritus in patients with chronic cholestatic liver disease. Gut, 1990, 31: 96-99 Methods SUBJECTS Forty two patients with cholestasis (33 women and nine men) were seen at The Thomas Jefferson University Hospital. These patients had a diagnosis of either primary biliary cirrhosis or primary sclerosing cholangitis. Thirty of the 42 patients had antimitochondrial antibodies positive and had liver biopsies compatible with primary biliary cirrhosis. This subgroup was predominantly female (93%) and had a mean age of 51-4 (9-9) (SD) years. Eighteen of the 30 patients were symptomatic with pruritus and of these, 11 were receiving cholestyramine and one was treated with antihistamines at the time of testing.
Twelve patients with primary sclerosing cholangitis (seven men and five women) had a mean age of 39-2 (11 -6) years. Four of the 12 had pruritus and one was being treated with cholestyramine. The diagnosis of primary sclerosing cholangitis was confirmed by endoscopic retrograde cholangiograms in all. Eight patients with primary sclerosing cholangitis had a concurrent diagnosis of inflammatory bowel disease: six with ulcerative colitis and two with Crohn's disease.
The mean age of the entire chronic cholestatic liver disease group was 47-9 (11 7) years (range 23 to 71 years). Of these 42 patients with chronic cholestasis, 22 complained ofpruritus and 20 did not. The mean age of the patients with pruritus (46 (9) years) was similar to those who did not have pruritus (50 (14) Plasma samples were assayed for histamine using a recently described highly sensitive and specific radioenzymatic assay.67 The assay is sensitive to histamine concentrations of less than 50 pg/ml plasma or 1-2 pg histamine added. The measurement of histamine is based on its conversion to a tritiated N-methylhistamine by a purified rat kidney histamine N-methyltransferase (HNMT) using (3H)S-adenosylmethionine (New England Nuclear Corporation, Boston) as the methyl donor.
All plasma samples were run in duplicate along with aqueous blanks. Each plasma sample was also run with an internal standard consisting of an aliquot of plasma spiked with 500 pg histamine. This point corresponded to the upper end of the linear portion of the standard curve. By quantitatively comparing the methylation of the plasma sample to the internal standard, the plasma histamine level of each sample was determined. Standard concentrations of histamine in water, or repeated aliquots of a single plasma sample, were tested to determine interassay variation. For plasma and aqueous specimens containing histamine in the range of 100 to 500 pg/ml, the interassay coefficient of variation was 18% which compares favourably with previously reported variations in double isotope89 and single isotope histamine assays.'0 The intra-assay coefficient of variation was 6%. Repeated assay of a single aliquoted plasma sample showed no degradation of histamine while stored frozen over a six month period.
HISTAMINASE ACTIVITY
Using a modification of the histamine assay, plasma histaminase activity was indirectly determined. By comparing the methylation of a 500 pg spike of histamine added to plasma to the same amount of histamine in water, the histaminase activity of plasma was determined. Histaminase (Table I ) and plasma histamine concentrations (Fig 1) . No significant differences were seen in the biochemical parameters for these two diseases. The degree of hyperbilirubinaemia was similar with a mean concentration of approximately 5 0 mg/dl. Hepatic synthetic function was generally well preserved in both groups as evidenced by normal mean serum albumin concentrations and prothrombin ratios. A five-fold rise in alkaline phosphatase, 15-fold increase in gamma-glutamyl transpeptidase and five-to sixfold increase in the aspartate aminotransferase were seen in both groups. Alanine aminotransferase, however, was slightly but significantly higher in the primary sclerosing cholangitis patients.
The mean plasma histamine concentrations in each chronic cholestatic liver disease subgroup was compared with an age and sex matched control subgroup, though within the entire control group, neither age nor gender correlated with plasma histamine concentrations. The 30 patients with primary biliary cirrhosis had a mean plasma histamine concentration of 297 (119) pg/ml which was significantly greater (p<0 01) than the control group which had a mean plasma histamine concentration of 136 (81) pg/ml (Fig 1) . The 12 patients with primary sclerosing cholangitis had a mean plasma histamine concentration of 220 (97) pg/ml which was significantly greater than the concentration of 140 (72) pg/ml (p<0 05) in the control group. There were no significant differences between the mean plasma histamine concentrations of the primary biliary cirrhosis and primary sclerosing cholangitis groups. Thus, the two cholestatic disease subgroups were not only biochemically similar but also had mean plasma histamine concentrations which were not significantly .E Figure 2 . The cholestatic patients with pruritus had a mean plasma histamine level of 319 (132) pg/ml which was significantly greater than the mean histamine level of non-pruritic patients (227 (75) pg/ml, p<0008).
The relationship between the higher concentrations of serum bilirubin and lower concentrations of serum albumin seen in the patients with pruritus was examined to determine if they significantly correlated with histamine concentrations. Neither bilirubin (r=-0 188) nor albumin (r=-0-120) significantly correlated with plasma histamine concentrations.
As previously noted, 12 The role(s) of histamine and bile acids (or some other yet to be identified pruritogen) need not be mutually exclusive. Some investigators have hypothesised that bile acids act directly on tissue mast cells resulting in the release of histamine and the subsequent development of pruritus. '4 Against this hypothesis is the current observation that among pruritic patients, the cholestyramine treatment group did not have lower plasma histamine concentrations than the noncholestyramine group. We did not, however, measure plasma histamine levels pre and post cholestyramine treatment which would be required to more rigorously evaluate this mechanism.
The histamine measurements performed in the present study have been made possible by the development of a more sensitive and specific assay.67 As the radioenzymatic assay for histamine has been improved, the range of normal values for plasma histamine has declined by at least an order of magnitude and, the assay is now sensitive enough to measure fluctuations in plasma histamine which may occur clinically. 10 
